EmVenio Research Partners with ClearDATA to Secure Clinical Trials in the Heart of Underserved Communities

by EmVenio | Mar 30, 2023 | Press Release

EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — ClearDATA®, the first and most comprehensive...

EmVenio Research prioritizes improving access to clinical research in Orlando with opening of community research site

by EmVenio | Mar 6, 2023 | Press Release

DURHAM, N.C., March 6, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...

EmVenio Research prioritizes improving access to clinical research with the opening of the Claremont Community Research Site

by EmVenio | Feb 21, 2023 | Press Release

DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Claremont, California, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...

EmVenio prioritizes inclusion in clinical research with new patient-centric model

by EmVenio | Feb 16, 2023 | Press Release

DURHAM, N.C., Feb. 16, 2023 – In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diverse populations across the United States. This concerted effort marks the value EmVenio’s...

GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial

by EmVenio | Feb 15, 2023 | Press Release

Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...

Ripple Enterprise to be an integral part of EmVenio Research’s Decentralized Clinical Trial (DCT) Platform

by EmVenio | Sep 15, 2022 | Press Release

Agreement signed for Ripple Enterprise patient engagement software to be deployed by EmVenio Research, making decentralized trials rapid and scalable. ANN ARBOR, MI, AND DURHAM, NC, USA, September 15, 2022 /EINPresswire.com/ — Ripple Science, a digital clinical...